NCT04749134 (MINION) is a clinical trial in Focus of the Study is MRI Sequence Development, sponsored by The Christie NHS Foundation Trust.

Who is sponsoring NCT04749134?

NCT04749134 is sponsored by The Christie NHS Foundation Trust.

What condition does NCT04749134 study?

NCT04749134 studies Focus of the Study is MRI Sequence Development.

Is NCT04749134 still recruiting?

NCT04749134 is currently recruiting now. Last updated 24 August 2025.

Last reviewed 2025-08-24 · How we verify

NCT04749134: MINION

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MRI Development for Radiotherapy Planning and Delivery in Non-Patient Volunteers

Recruiting now Last updated 24 August 2025

What this trial tests

trial in Focus of the Study is MRI Sequence Development in 500 participants. Currently enrolling.

Timeline

1 August 2021

Primary endpoint
31 August 2028

31 August 2028

Quick facts

Lead sponsor	The Christie NHS Foundation Trust
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	500
Start date	1 August 2021
Primary completion	31 August 2028
Estimated completion	31 August 2028
Sites	1 location across United Kingdom

Conditions studied

Focus of the Study is MRI Sequence Development — all drugs for Focus of the Study is MRI Sequence Development →

Sponsor

The Christie NHS Foundation Trust

Who can join

16 and older, any sex, with Focus of the Study is MRI Sequence Development. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Non-patient volunteers will be scanned on the MR-Linac and MRSIM to facilitate the development, optimisation and validation of MRI protocols at The Christie NHS Foundation Trust.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other The Christie NHS Foundation Trust trials

Trials by the same sponsor.

NCT07183267 — Using Red Light Therapy to Ease Skin Side Effects and Mouth Side Effects, in Children and Young People Aged 0 to 16 Year · NA · not yet recruiting
NCT07268339 — A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calme · Phase 3 · not yet recruiting
NCT06965101 — To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compr · NA · recruiting
NCT05903430 — A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION) · recruiting
NCT07202260 — Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the Lung · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04749134 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Christie NHS Foundation Trust
Last refreshed: 24 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04749134.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing